Emergent BioSolutions Inc. — Director's Dealing 2017

Dec 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2017-12-07

Reporting Person: Harsanyi Zsolt (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-07	Common Stock	S	7000	$42.47	Disposed	37077	Direct

Footnotes

F1: Consists of vested restricted stock units granted under the Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended and restated.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.35 to $42.59, inclusive.